Switch to:
Hi-Tech Pharmacal Co., Inc. (NAS:HITK)
Days Accounts Payable
31.44 (As of Jan. 2014)

Hi-Tech Pharmacal Co., Inc.'s accounts payable for the three months ended in Jan. 2014 was $9.6 Mil. Hi-Tech Pharmacal Co., Inc.'s cost of goods sold for the three months ended in Jan. 2014 was $28.0 Mil. Hence, Hi-Tech Pharmacal Co., Inc.'s days accounts payable for the three months ended in Jan. 2014 was 31.44.

Hi-Tech Pharmacal Co., Inc.'s days accounts payable increased from Jan. 2013 (28.64) to Jan. 2014 (31.44). It may suggest that Hi-Tech Pharmacal Co., Inc. delayed paying its suppliers.


Definition

Days Accounts Payable indicates the number of days that the accounts payable relative to cost of goods sold the company has. An increase of Days Accounts Payable may suggest that the company delays paying its suppliers.

Hi-Tech Pharmacal Co., Inc.'s Days Accounts Payable for the fiscal year that ended in Apr. 2013 is calculated as

Days Accounts Payable=Accounts Payable/COGS*Days in Period
=9.768/117.304*365
=30.39

Hi-Tech Pharmacal Co., Inc.'s Days Accounts Payable for the quarter that ended in Jan. 2014 is calculated as:

Days Accounts Payable=Accounts Payable/COGS*Days in Period
=9.635/27.962*365 / 4
=31.44

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Accounts Payable, COGS


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Hi-Tech Pharmacal Co., Inc. Annual Data

Apr04Apr05Apr06Apr07Apr08Apr09Apr10Apr11Apr12Apr13
Days Accts Payable 63.0962.9754.3133.0943.0139.9628.6934.2260.0930.39

Hi-Tech Pharmacal Co., Inc. Quarterly Data

Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13Jan14
Days Accts Payable 35.8245.9851.4033.0131.8128.6428.5854.6145.1731.44
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK